Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer

Pharmacogenetics

Volumn 8, Issue 6, 1998, Pages 495-502

  Jourenkova Mironova, Nadejda ^a   Wikman, Harriet ^b   Bouchardy, Christine ^c   Voho, Anu ^b   Dayer, Pierre ^d   Benhamou, Simone ^a   Hirvonen, Ari ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c GENEVA CANCER REGISTRY   (Switzerland)

^d NONE

Author keywords

Epidemiology; Glutathione transferases; Lung neoplasms; Polymorphism

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG METABOLISM; GENE MAPPING; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; STATISTICAL ANALYSIS;

NICOTIANA TABACUM; TRIXIS;

EID: 0032441665     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199812000-00006     Document Type: Article

References (35)

1. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Eschcrichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997; 272:10004-10012.
2. Anttila S, Hirvonen A, Vainio H, Husgafvel-Pursiainen K, Hayes JD, Ketterer B. Immunohistochemical localization of glutathione S-transferases in human lung. Cancer Res 1993; 53:5643-5648.
3. Anttila S, Luostarinen L, Hirvonen A, Elovaara E,. Karjalainen A, Nurminen T, et al. Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: association with GSTM1 polymorphism, smoking, and asbestos exposure. Cancer Res 1995; 55:3305-3309.
4. Becker KG, Jedlicka P, Templeton NS, Liotta L, Ozato K. Characterization of hUCRBP (YY1, NF-E1. delta): a transcription factor that binds the regulatory regions of many viral and cellular genes. Gene 1994; 150:259-266.
5. Bouchardy C, Benhamou S, Dayer P. The effect of tobacco on lung cancer risk depends on CYP2D6 activity. Cancer Res 1996; 56:251-253.
6. Breslow NE, Day NE. The analysis of case-control studies. In: Statistical methods in cancer research. Vol. 1, no. 32. Lyon, France: International Agency for Research on Cancer: 1980. pp. 192-242.
7. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 1996; 347:295-297.
8. Deakin M, Elder J, Hendrickse C, Peckham D, Baldwin D, Pantin C, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 1996; 17:881-884.
9. Garcia-Closas M, Kelsey KT, Wiencke JK, Xu N, Wain JC, Christiani DC. A case-control study of cytochrome P450 1A1, glulathione S-transferase M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States). Cancer Causes Control 1997; 8:544-555.
10. Guengerich FP, Thier R, Persmark M, Taylor JB, Pemble SE, Ketterer B. Conjugation of carcinogens by theta class glutathione S-transferases: mechanisms and relevance to variations in human risk. Pharmacogenetics 1995; 5:S103-S107.
11. Hand PA, Inskip A, Gilford J, Alldersea J, Elexpuru-Camiruaga J, Hayes JD, et al. Allelism at the glutathione S-transferase GSTM3 locus: interactions with GSTM1 and GSTT1 as risk factors for astrocytoma. Carcinogenesis 1996; 17:1919-1922.
12. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997; 18:641-644.
13. Harris MJ, Coggan M, Langton L, Wilson SR, Board PG. Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics 1998; 8:27-31.
14. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Vainio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 1993; 14:1479-1481.
15. Hirvonen A, Saarikoski ST, Linnainmaa K, Koskinen K, Husgafvel-Pursiainen K, Mattson K, Vainio H. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J Natl Cancer Inst 1996; 88:1853-1856.
16. Hirvonen A. Combinations of susceptible genotypes and individual responses to toxicants. Environ Health Perspect 1997; 105(Suppl 4):755-758.
17. Inskip A, Elexperu-Camiruaga J, Buxton N, Dias PS, MacIntosh J, Campbell D, et al. Identification of polymorphism at the glutathione S-transferase. GSTM3 locus: evidence for linkage with GSTM1*A. Biochem J 1995; 312:713-716.
18. Jahnke V, Strange R, Matthias C, Fryer A. Glutathione S-transferase and cytochrome P450 genotypes as risk factors for laryngeal carcinoma. Eur Arch Otorhinolaryngol 1997; 1:S147-S149.
19. Jourenkova N, Reinikainen M, Bouchardy C, Dayer P, Benhamou S, Hirvonen A. Effects of glutathione S-transferase GSTM1 and GSTT1 genotypes on lung cancer risk in smokers. Pharmacogenetics 1997; 7:515-518.
20. Ketterer B, Harris JM, Talaska G, Meyer DJ, Pemble SE, Taylor JB, et al. The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect 1992; 98:87-94.
21. Ketterer B, Taylor J, Meyer D, Pemble S, Coles B, ChuLin X, Spencer S. Some functions of glutathione transferases. In: Tew KD, Pickett CB, Mantle TJ, Mannervik B, Hayes JD, editors. Structure and function of glutathione tranferases. Boca Ranton: CRC Press: 1993. pp. 15-27.
22. Kihara M, Kihara M, Noda K. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis 1994; 15:415-418.
23. Nakajima T, Elovaara E, Anttila S, Hirvonen A, Camus AM, Hayes JD, et al. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis 1995; 16:707-711.
24. Park J, Kaur T, Schantz S, Harwick R, Stern J, Muscat J, Lazarus P. Interethnic variability and genetic linkage in GSTM1 and GSTM3 polymorphic frequencies [abstract]. Proc Am Assoc Cancer Res 1997; 38:213.
25. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, et al. Human glntathione S-transferase theta GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300:271-276.
26. Rebbeck TR. Molecular epidemiology of the human glntathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997; 6:733-743.
27. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997; 18:1285-1289.
28. SAS Institute Inc. Logistic regression examples using the SAS system, version 6. 1st ed. Cary. NC: SAS Institute Inc: 1995.
29. SAS Institute Inc. SAS users guide: statistics, version 6.11 Cary. NC: SAS Institute Inc: 1996.
30. Siedegard J, Vorachek WR, Pero RW. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988; 85:7293-7297.
31. Strange R. Glutathione S-transferases and cancer susceptibility. In: Vermeulen NPE, Mulder GJ, Niewenhuyse H, Peters WHM, Van Bladeren PJ, editors. Glutathione S-transferases: structuer function and clinical implications. London: Taylor & Francis: 1996. pp. 239-248.
32. To-Figueras J, Gene M, Gomez-Catalan J, Galan MC, Firvida J, Fuentes M, et al. Glutathione S-transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1996; 5:337-342.
33. To-Figueras J, Gene M, Gomez-Catalan J, Galan C, Fuentes M, Ramon J, et al. Glulathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans. Carcinogenesis 1997; 18:1529-1533.
34. Vineis P. Molecular epidemiology: low-dose carcinogens and genetic susceptibility. Int J Cancer 1997; 71:1-3.
35. Yengi L, Inskip A, Gilford J, Alldersea J, Bailey L, Smith A, et al. Polymorphism at the glutalhione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res 1996; 56:1974-1977.